Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Titova Olga (Saint-Petersburg, Russian Federation), Titova Olga, Sklyarova Darya, Kuzubova Natalia, Gichkin Aleksey. Potential markers of the progression of CRF in patients with COPD. Eur Respir J 2015; 46: Suppl. 59, 667

Member's Comments

No comment yet.

Related content which might interest you: Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Microalbuminuria as a cardiovascular biomarker in patients with COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Relation of plasma osteopontin levels with the clinical course in patients with COPD Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Markers of ageing in the limb muscle of patients with COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Hydrogen sulfide (H2S) in sputum and serum as a novel biomarker of COPD Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Modeling of oxygen uptake kinetics during exercise testing in patients with chronic obstructive pulmonary diseases (COPD) Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Altered P2 receptor expression profile in sputum cells of patients with COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Serum sirtuin-1 is reduced in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Variants of apelin gene and COPD Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Decisive factors during treadmill and cycle exercise in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement Year: 2015 Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Growth differentiation factor-15 is a predictor for COPD exacerbations and survival Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015